In vitro diagnostic devices
FDA releases final guidance on validating in‑vitro diagnostic devices for emerging pathogens during Section 564 emergencies
The U.S. Food and Drug Administration announced that a final guidance titled “Validation of Certain In Vitro Diagnostic Devices for Emerging Pathogens During a Section 564 Declared Emergency” is now available. The…
1 source3 claims checked5d ago
3 unverifiable
Biblical perspectiveINSUFFICIENT CONTEXT
Full analysis